Surgery Partners, Inc. (SGRY)

In the past six months, Surgery Partners, Inc. (SGRY) stock broke above its 200-day moving average on October 24, 2025, which is a bullish indicator, and experienced oversold conditions earlier in October 2025. On October 28, 2025, Duly Health and Care announced the acquisition of a minority ownership interest in Valley Ambulatory Surgery Center in partnership with Surgery Partners. Surgery Partners announced its Third Quarter 2025 Earnings Release Date and Conference Call Details on October 24, 2025. In September 2025, the share price was reported as $21.59, down from $32.21 on September 26, 2024. In Q2 2025, the company reported revenues of $667.6 million, an 8.5% year-over-year increase, driven by volume and rate changes.

The provided search results do not explicitly detail the demand seasonality for Surgery Partners, Inc.'s products and services. The company operates within the outpatient surgical industry, a segment experiencing significant demand driven by advancements in medical technology and a growing preference for minimally invasive procedures. The company's growth initiatives include increasing case volume across all core specialties, with gastroenterology (GI) and musculoskeletal (MSK) procedures leading the way. Generally, healthcare services, particularly elective procedures, can experience some seasonality, with potential fluctuations around holidays or during certain times of the year when patients may be more likely to schedule procedures due to deductibles or vacation time.

Surgery Partners, Inc. (SGRY) is a healthcare services company operating a national network of surgical facilities and ancillary services in the United States, focusing on high-quality, cost-effective outpatient surgical and related care. The company operates ambulatory surgery centers (ASCs) and surgical hospitals, offering non-emergency surgical procedures across various specialties, including orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. It also provides integrated ancillary services such as anesthesia, multi-specialty physician practices, urgent care, diagnostic imaging, pharmacy, and optical services. As of late 2024, Surgery Partners operated over 180 locations.

Surgery Partners, Inc. has a significant geographic footprint across the United States, operating in more than 250 locations in 30 states, over 200 locations in 31 states (including short-stay surgical hospitals), and over 180 locations in 33 states. Its network serves a diverse patient population and collaborates with physicians and healthcare professionals in numerous metropolitan and suburban areas.

The provided information does not contain specific details about Surgery Partners, Inc.'s brand reputation in the past year or any events that have explicitly affected it. The company emphasizes its mission to enhance patient quality of life through partnership and its focus on providing high-quality, cost-effective solutions for surgical and related ancillary care, evidenced by historically strong patient satisfaction rates and physician retention trends. The company focuses on organic growth, margin improvement, and capital deployment for mergers and acquisitions, with strong volume growth across core specialties and physician recruitment initiatives.

Surgery Partners, Inc.'s ownership is predominantly held by institutional investors, with a significant controlling interest held by affiliates of Bain Capital Private Equity. As of recent filings, Surgery Partners, Inc. (US:SGRY) has 461 institutional owners and shareholders holding a total of 170,384,119 shares. Major institutional owners include Bain Capital Investors Llc, Janus Henderson Group Plc, Fmr Llc, The Vanguard Group, Inc., Pentwater Capital Management LP, King Street Capital Management, L.P., BlackRock, Inc., Clearbridge Investments, LLC, Dimensional Fund Advisors LP, and UBS Asset Management AG. Top mutual fund holders include Janus Investment Fund - Janus Henderson Contrarian Fund, Vanguard Index Funds - Vanguard Total Stock Market ETF, and iShares Trust - iShares Russell 2000 ETF. Shares are also held by the general public and insiders (excluding Bain), and insider selling activity has been reported over the last 24 months.